This seems to give more weight to a merger with API once (if) the 900m comes through... With the possibility of other pharmaceuticals following suit this could mean bad times for the wholesale industry if big names want to go direct to retail..? At least if the SIP and API relationship was given ACCC blessing then they could negotiate better terms for the generics they will no doubt be buying of Aspen..!
This seems to give more weight to a merger with API once (if)...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)